Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

NCT01795950 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: PLX-PAD

Sponsor

United Therapeutics